Adverum Biotechnologies Inc (ADVM)
8.25
-0.50
(-5.71%)
USD |
NASDAQ |
May 16, 16:00
8.235
-0.02
(-0.18%)
After-Hours: 20:00
Adverum Biotechnologies Shareholders Equity (Quarterly): 182.29M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 182.29M |
| December 31, 2023 | 83.47M |
| September 30, 2023 | 102.71M |
| June 30, 2023 | 131.16M |
| March 31, 2023 | 157.76M |
| December 31, 2022 | 181.52M |
| September 30, 2022 | 208.34M |
| June 30, 2022 | 244.12M |
| March 31, 2022 | 282.95M |
| December 31, 2021 | 316.18M |
| September 30, 2021 | 346.00M |
| June 30, 2021 | 379.14M |
| March 31, 2021 | 414.82M |
| December 31, 2020 | 434.35M |
| September 30, 2020 | 464.71M |
| June 30, 2020 | 282.56M |
| March 31, 2020 | 303.95M |
| December 31, 2019 | 174.96M |
| September 30, 2019 | 164.21M |
| June 30, 2019 | 177.74M |
| March 31, 2019 | 188.14M |
| Date | Value |
|---|---|
| December 31, 2018 | 201.17M |
| September 30, 2018 | 215.55M |
| June 30, 2018 | 233.45M |
| March 31, 2018 | 246.04M |
| December 31, 2017 | 184.03M |
| September 30, 2017 | 180.99M |
| June 30, 2017 | 192.18M |
| March 31, 2017 | 201.38M |
| December 31, 2016 | 215.60M |
| September 30, 2016 | 236.23M |
| June 30, 2016 | 247.65M |
| March 31, 2016 | 241.57M |
| December 31, 2015 | 252.59M |
| September 30, 2015 | 262.33M |
| June 30, 2015 | 270.63M |
| March 31, 2015 | 279.68M |
| December 31, 2014 | 149.48M |
| September 30, 2014 | 155.74M |
| June 30, 2014 | 43.04M |
| March 31, 2014 | 49.91M |
| December 31, 2013 | -0.218M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
83.47M
Minimum
Dec 2023
464.71M
Maximum
Sep 2020
251.65M
Average
226.23M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 806.52M |
| Ardelyx Inc | 150.89M |
| Arcus Biosciences Inc | 707.00M |
| Arcutis Biotherapeutics Inc | 224.94M |
| SeaStar Medical Holding Corp | -13.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 267.83M |
| Total Liabilities (Quarterly) | 85.54M |